Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
12
Number of overlapping holdings
17.1%
% of PSCH's 70 holdings also in XPH
29.3%
% of XPH's 41 holdings also in PSCH
Overlap by Weight
Sector Drift (PSCH minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PSCH |
Weight in XPH |
Overlap | |
|---|---|---|---|---|
 |
CORCEPT THERAPEUTICS INC | 3.4% | 3.7% | 3.4% |
|
PRESTIGE BRANDS HOLDINGS INC | 2.8% | 3.6% | 2.8% |
|
ORGANON & CO. | 2.5% | 3.6% | 2.5% |
|
LIGAND PHARMACEUTICALS-CL B | 1.4% | 1.7% | 1.4% |
|
SUPERNUS PHARMACEUTICALS INC | 1.2% | 2.0% | 1.2% |
Position Highlights (Non-Overlapping Exposures)
PSCH Overweight Relative to XPH
|
TELEFLEX INC | 4.3% |
|
MERIT MEDICAL SYSTEMS INC | 4.0% |
|
GLAUKOS CORP | 3.8% |
 |
ALKERMES PLC | 3.6% |
|
TG THERAPEUTICS INC | 3.6% |
|
ADMA BIOLOGICS, INC. | 3.2% |
|
INSPIRE MEDICAL SYSTEMS, INC. | 3.1% |
|
KRYSTAL BIOTECH, INC. | 3.1% |
|
INTEGER HOLDINGS CORPORATION | 2.6% |
|
ICU MEDICAL INC | 2.3% |
PSCH Underweight Relative to XPH
|
TARSUS PHARMACEUTICALS, INC. | -3.9% |
|
PERRIGO CO | -3.8% |
|
ZOETIS INC | -3.7% |
|
JOHNSON & JOHNSON | -3.7% |
|
INTRA-CELLULAR THERAPIES INC | -3.7% |
|
BRISTOL-MYERS SQUIBB CO | -3.7% |
|
ELANCO ANIMAL HEALTH, INC. | -3.7% |
|
ELI LILLY & CO | -3.7% |
|
AXSOME THERAPEUTICS, INC. | -3.7% |
|
PFIZER INC | -3.6% |